Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) |
| BNF code | 0803042N0BBADAD |
| Virtual Medicinal Product | Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes |
| Name | Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes |
| Abbreviated name | Prostap 3 DCS 11.25mg inj pre-filled syringes |
| Supplier | Takeda UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.